Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-08
2006-08-08
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S297000
Reexamination Certificate
active
07087617
ABSTRACT:
This invention relates to compounds of Formula I,a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, or a pharmaceutically acceptable salt of a prodrug thereof. The compounds interact with CRF1receptors, including human CRF1receptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety-related disorders such as anxiety, and mood disorders such as major depression.
REFERENCES:
patent: 6043260 (2000-03-01), Chen et al.
patent: 1097709 (2000-10-01), None
patent: 9639400 (1996-12-01), None
patent: 0160806 (2001-08-01), None
patent: 0168614 (2001-09-01), None
patent: WO 01/68614 (2001-09-01), None
patent: WO 200168614 (2001-09-01), None
Corbett Jeffrey W.
Ennis Michael Dalton
Frank Kristine E.
Fu Jian-Min
Hoffman Robert Louis
Benson Gregg C.
Grazier Nyeemah
Munchhof Martha G.
Pfizer Inc.
Saeed Kamal A.
LandOfFree
Substituted pyrimidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrimidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrimidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3703217